Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cystic fibrosis transmembrane conductance regulator pseudogene 2 (CFTRP2) is a non-coding genomic sequence that closely resembles the functional CFTR gene but does not produce a functional protein product. It is classified as a pseudogene and is not involved in normal physiology or disease causation. While CFTRP2 itself has no direct biological or pathological function, sequence similarity with the functional CFTR gene can occasionally cause confusion in genetic analyses, such as false positive results in carrier screening or diagnostic workflows for cystic fibrosis[8]. CFTRP2 should not be confused with the main disease-associated target, CFTR, which encodes a chloride channel critical for epithelial ion transport and is the basis for diseases such as cystic fibrosis[1][3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cystic fibrosis transmembrane conductance regulator pseudogene 2 (CFTRP2).